Literature DB >> 1458583

Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions.

R Naidoo1, M L Knapp.   

Abstract

Lipid peroxides were measured in cerebrospinal fluid (CSF) and sera from patients with multiple sclerosis (MS) or other conditions and from control subjects. In serum, visible fluorescence, A240nm, and free and protein-bound thiobarbituric acid (TBA)-reactive substances were significantly greater in MS patients than in control subjects. No such differences were observed in CSF. There was no correlation between lipid peroxides and disease severity or relapse time. We observed a significant positive correlation between CSF protein-bound TBA-reactive substances and CSF protein, suggesting that production of the former depends on protein concentration. A significant negative correlation between free TBA-reactive substances in serum and ultraviolet fluorescence indicated that production of free TBA-reactive substances may be associated with decreased production of fluorescent lipid peroxides. This study provides evidence for increased lipid peroxidation in serum but not CSF from MS patients, suggesting that either there is no increase in CSF lipid peroxidation in MS patients or that CSF lipid peroxides are rapidly removed, possibly by binding to CSF proteins that can be reabsorbed into the blood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458583

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  23 in total

Review 1.  Antioxidants in multiple sclerosis: do they have a role in therapy?

Authors:  Noel G Carlson; John W Rose
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Dragan Stojanov; Svetlana Stojanovic; Gordana Kocic; Dejan Savic; Tatjana Cvetkovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.046

3.  T-cell recognition of lipid peroxidation products breaks tolerance to self proteins.

Authors:  D M Wuttge; M Bruzelius; S Stemme
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

4.  Lp-PLA2: inflammatory biomarker of vascular risk in multiple sclerosis.

Authors:  Zohara Sternberg; Alison Drake; Daniel S Sternberg; Ralph H B Benedict; Fan Li; David Hojnacki; Bianca Weinstock-Guttmann; Frederick E Munschauer
Journal:  J Clin Immunol       Date:  2012-01-13       Impact factor: 8.317

Review 5.  The role of melatonin in Multiple Sclerosis.

Authors:  Charalampos Skarlis; Maria Anagnostouli
Journal:  Neurol Sci       Date:  2019-12-16       Impact factor: 3.307

Review 6.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

7.  Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.

Authors:  Mariana Vaini de Freitas; Marcela Ramos de Oliveira; Diogo Fernandes dos Santos; Rita de Cássia Mascarenhas Netto; Sheila Bernardino Fenelon; Nilson Penha-Silva
Journal:  J Membr Biol       Date:  2010-02-10       Impact factor: 1.843

8.  Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.

Authors:  Marcus Koch; Geeta S M Ramsaransing; Alexander V Arutjunyan; Michael Stepanov; Albert Teelken; Dorothea J Heersema; Jacques De Keyser
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

9.  Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.

Authors:  Jofre Tenorio-Laranga; Francisco Coret-Ferrer; Buenaventura Casanova-Estruch; María Burgal; J Arturo García-Horsman
Journal:  J Neuroinflammation       Date:  2010-04-06       Impact factor: 8.322

Review 10.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.